<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Maintenance of telomeres has been identified as an essential regulator of proliferative capacity and genomic integrity in <z:mp ids='MP_0002018'>malignant tumors</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The authors evaluated telomere length and telomerase subunits, hTR and hTERT, as prognostic markers in patients with Barrett <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Telomere length was measured by Southern blot analysis and hTR expression and hTERT expression by real-time polymerase chain reaction in both <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue and adjacent noncancerous Barrett mucosa in resection specimens from 46 patients with Barrett <z:mp ids='MP_0002038'>carcinoma</z:mp> (International Union Against <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> [UICC] stages I-III) </plain></SENT>
<SENT sid="3" pm="."><plain>The median follow-up time of the surviving patients was 79 months </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> tissue expressed more hTERT-<z:chebi fb="2" ids="33699">mRNA</z:chebi> than noncancerous mucosa (P &lt; .05) </plain></SENT>
<SENT sid="5" pm="."><plain>Telomere lengths in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue and in noncancerous mucosa increased with higher pT category (P = .08 and P = .05, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>Twenty-one patients who died of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> recurrence showed significantly longer telomeres in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue compared with 25 patients without <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-related <z:hpo ids='HP_0011420'>deaths</z:hpo> (P &lt; .05) </plain></SENT>
<SENT sid="7" pm="."><plain>Telomere length in both <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissue and in noncancerous mucosa and the telomere-length ratio <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>:noncancerous tissue were correlated with overall survival </plain></SENT>
<SENT sid="8" pm="."><plain>In multivariate analysis, the telomere-length ratio proved to be an independent prognostic parameter (P &lt; .02; relative risk of <z:hpo ids='HP_0011420'>death</z:hpo> 3.4; confidence interval, 1.3-8.9) </plain></SENT>
<SENT sid="9" pm="."><plain>Ten patients with telomere-length ratios &gt;1.17 had a significantly poorer overall survival compared with 36 patients with telomere-length ratios &lt;or=1.17 with 5-year survival rates of 0% and 60%, respectively (P &lt; .02) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Telomere length and telomerase subunits were identified as diagnostic and prognostic biomarkers for Barrett <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>Genetic alterations found in adjacent noncancerous mucosa suggested a "field effect" in Barrett <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
</text></document>